Welcome to LookChem.com Sign In|Join Free

CAS

  • or
N-(4-phenylthiazol-2-yl)-2-naphthamide is a chemical with a specific purpose. Lookchem provides you with multiple data and supplier information of this chemical.

475044-85-0

Post Buying Request

475044-85-0 Suppliers

Recommended suppliersmore

  • Product
  • FOB Price
  • Min.Order
  • Supply Ability
  • Supplier
  • Contact Supplier

475044-85-0 Usage

Check Digit Verification of cas no

The CAS Registry Mumber 475044-85-0 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 4,7,5,0,4 and 4 respectively; the second part has 2 digits, 8 and 5 respectively.
Calculate Digit Verification of CAS Registry Number 475044-85:
(8*4)+(7*7)+(6*5)+(5*0)+(4*4)+(3*4)+(2*8)+(1*5)=160
160 % 10 = 0
So 475044-85-0 is a valid CAS Registry Number.

475044-85-0Downstream Products

475044-85-0Relevant articles and documents

Design and synthesis of thiazole derivatives as potent FabH inhibitors with antibacterial activity

Li, Jing-Ran,Li, Dong-Dong,Wang, Rong-Rong,Sun, Jian,Dong, Jing-Jun,Du, Qian-Ru,Fang, Fei,Zhang, Wei-Ming,Zhu, Hai-Liang

, p. 438 - 447 (2014)

Components of fatty acid biosynthetic pathway have been identified as attractive targets for the development of new antibacterial agents. Compounds of series A (4a-4g) and series B (5a-5g) were synthesized by the formation of an amine bond between aromati

Design, synthesis and antibacterial activity studies of thiazole derivatives as potent ecKAS III inhibitors

Cheng, Kui,Xue, Jia-Yu,Zhu, Hai-Liang

supporting information, p. 4235 - 4238 (2013/07/26)

Two series of thiazole derivatives containing amide skeleton were synthesized and developed as potent Escherichia coli β-ketoacyl-(acyl- carrier-protein) synthase III (ecKAS III) inhibitors. All the 24 new synthesized compounds were assayed for antibacterial activity against the respective Gram-negative and Gram-positive bacterial strains, including E. coli, Pseudomonas aeruginosa, Bacillus subtilis and Staphylococcus aureus. In which, 10 compounds with broad-spectrum antibacterial activities were further tested for their ecKAS III inhibitory activity. Last, we have successfully found that compound 4e showed both the promising broad antibacterial activity with MIC of 1.56-6.25 μg/mL against the representative bacterial stains, and also processed the most potent ecKAS III inhibitory activity with IC50 of 5.3 μM. In addition, docking simulation also carried out in this study to give a potent prediction binding mode between the small molecule and ecKAS III (PDB code: 1hnj) protein.

Post a RFQ

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

1

What can I do for you?
Get Best Price

Get Best Price for 475044-85-0